Stribild 150 mg - 150 mg - 200 mg - 245 mg (cobicistat 150 mg + elvitegravir 150 mg + emtricitabine 200 mg + tenofovir disoproxil 245 mg tablet (or.)) · CNK 3111283

Product information

Stribild 150 mg - 150 mg - 200 mg - 245 mg
30
cobicistat 150 mg + elvitegravir 150 mg + emtricitabine 200 mg + tenofovir disoproxil 245 mg tablet (or.)
3111283
3.9 / 10
Locked

Product properties

1004316-88-4
J05AR09
Gilead Sciences Ireland UC
Film-coated tablet
€773.38
EU/1/13/830/001
05391507140791
M42
Public
440973-01

Pharmacist Assessment

Structurally fluctuating availability

This product has chronically fluctuating availability (current 3.9/10, historical 🔒/10). Be prepared for possible supply issues and consider keeping an alternative in stock.

No available alternative found in the system. Consult the physician for a therapeutic alternative.

Equivalent products

Tier A: Direct equivalents

Tier B: Galenic alternatives

Tier C: Strength alternatives

Tier D: ATC equivalents (parallel import)

Tier E: Active substances (magistral)

Stock overview

Availability in Freemium
  • 11 of 18 warehouse locations have stock
  • 3 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Status history (PharmaStatus)

Available Active

Composition

7 ingredients

Substance Type Strength CAS
Active ingredient
200 mg
143491-57-0
Active ingredient
202138-50-9
Active ingredient
150 mg
697761-98-1
Active ingredient
150 mg
1004316-88-4
Excipient
Excipient
Excipient

Additional information

Availability statistics

Available
0 days
1
0